Valor202020212022202320242025TTMCash from investing activities-49.56 M12.69 M8.46 M8.62 M-8.13 M-6.17 M-6.17 MCash from financing activities91.78 M34.29 M4.19 M10.67 M4.96 M231 K231 KFree cash flow-42.36 M-34.83 M-27.61 M-47.77 M8.52 M1.11 M1.11 M
Cerus Corporation
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.